AquaBounty (AQB) 10-K 10 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Mar. 09, 2022	Jun. 30, 2021
Document and Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	001-36426
Entity Registrant Name	AquaBounty Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	04-3156167
Entity Address, Address Line One	2 Mill & Main Place
Entity Address, Address Line Two	Suite 395
Entity Address, City or Town	Maynard
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01754
City Area Code	978
Local Phone Number	648-6000
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	AQB
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 234.2
Entity Common Stock, Shares Outstanding		71,025,738
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for its Annual Meeting of Shareholders to be held on May 17, 2022 (the “2022 Proxy Statement”), are incorporated by reference into Part III of this Annual Report on Form 10‑K.
Entity Central Index Key	0001603978
Auditor Name	Deloitte & Touche LLP
Auditor Location	Baltimore, Maryland
Auditor Firm ID	34

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 88,454,988	$ 95,751,160
Marketable securities	101,773,781
Inventory, net	1,259,910	1,525,377
Prepaid expenses and other current assets	1,536,484	405,370
Total current assets	193,025,163	97,681,907
Property, plant and equipment, net	33,815,119	26,930,338
Right of use assets, net	284,320	341,997
Intangible assets, net	231,842	245,546
Restricted cash	1,000,000	500,000
Other assets	79,548	76,715
Total assets	228,435,992	125,776,503
Current liabilities:
Accounts payable and accrued liabilities	4,317,615	1,176,802
Accrued employee compensation	874,589	583,301
Current debt	627,365	259,939
Other current liabilities	66,269	62,483
Total current liabilities	5,885,838	2,082,525
Long-term lease obligations	224,058	290,327
Long-term debt, net	8,523,333	8,528,490
Total liabilities	14,633,229	10,901,342
Commitments and contingencies (Note 10)
Stockholders’ equity:
Common stock, $0.001 par value, 80,000,000 shares authorized; 71,025,738 and 55,497,133 shares outstanding at December 31, 2021 and 2020, respectively	71,026	55,497
Additional paid-in capital	384,852,107	263,629,116
Accumulated other comprehensive loss	(255,588)	(267,258)
Accumulated deficit	(170,864,782)	(148,542,194)
Total stockholders’ equity	213,802,763	114,875,161
Total liabilities and stockholders’ equity	$ 228,435,992	$ 125,776,503

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Consolidated Balance Sheets [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	80,000,000	80,000,000
Common stock, shares outstanding (in shares)	71,025,738	55,497,133

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues
Product revenues	$ 1,174,832	$ 127,663
Costs and expenses
Product costs	10,786,072	6,680,012
Sales and marketing	1,261,764	533,428
Research and development	2,145,548	2,364,610
General and administrative	9,103,213	6,797,443
Total costs and expenses	23,296,597	16,375,493
Operating loss	(22,121,765)	(16,247,830)
Other income (expense)
Interest expense	(316,442)	(152,367)
Other income (expense), net	115,619	212
Total other income (expense)	(200,823)	(152,155)
Net loss	(22,322,588)	(16,399,985)
Other comprehensive income (loss):
Foreign currency	51,771	92,902
Unrealized losses on marketable securities	(40,101)
Total other comprehensive income	11,670	92,902
Comprehensive loss	$ (22,310,918)	$ (16,307,083)
Basic and diluted net loss per share	$ (0.32)	$ (0.45)
Weighted average number of common shares - basic and diluted	69,428,061	36,347,398

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Total
Beginning balance (in shares) at Dec. 31, 2019	21,635,365
Beginning balance at Dec. 31, 2019	$ 21,635	$ 156,241,363	$ (360,160)	$ (132,142,209)	$ 23,760,629
Net loss				(16,399,985)	(16,399,985)
Other comprehensive income			92,902		92,902
Issuance of common stock for service (in shares)	20,000
Issuance of common stock for service	$ 20	40,580			40,600
Issuance of common stock, net of expenses (in shares)	33,028,000
Issuance of common stock, net of expenses	$ 33,028	104,592,587			104,625,615
Exercise of warrants for common stock (in shares)	713,449
Exercise of warrants for common stock	$ 713	2,317,996			2,318,709
Share based compensation (in shares)	100,319
Share based compensation	$ 101	436,590			436,691
Ending balance (in shares) at Dec. 31, 2020	55,497,133
Ending balance at Dec. 31, 2020	$ 55,497	263,629,116	(267,258)	(148,542,194)	114,875,161
Net loss				(22,322,588)	(22,322,588)
Other comprehensive income			11,670		11,670
Cashless exercise of options for common stock (in shares)	4,354
Cashless exercise of options for common stock	$ 4	(4)
Issuance of common stock, net of expenses (in shares)	14,950,000
Issuance of common stock, net of expenses	$ 14,950	119,105,487			119,120,437
Exercise of warrants for common stock (in shares)	530,414
Exercise of warrants for common stock	$ 530	1,723,316			1,723,846
Share based compensation (in shares)	43,837
Share based compensation	$ 45	394,192			394,237
Ending balance (in shares) at Dec. 31, 2021	71,025,738
Ending balance at Dec. 31, 2021	$ 71,026	$ 384,852,107	$ (255,588)	$ (170,864,782)	$ 213,802,763

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating activities
Net loss	$ (22,322,588)	$ (16,399,985)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	1,787,564	1,494,596
Share-based compensation	394,237	436,691
Other non-cash charge	17,386	44,339
Changes in operating assets and liabilities:
Inventory	267,833	(282,260)
Prepaid expenses and other assets	(1,138,691)	(74,621)
Accounts payable and accrued liabilities	230,712	145,607
Accrued employee compensation	291,288	346,812
Net cash used in operating activities	(20,472,259)	(14,288,821)
Investing activities
Purchases of property, plant and equipment	(5,668,696)	(3,975,135)
Deposits on equipment purchases	(45,111)	(349,847)
Proceeds from sale of equipment		99,816
Purchases of marketable securities, net	(101,813,882)
Proceeds from legal settlement, net		1,014,008
Other investing activities	(11,010)	(27,253)
Net cash used in investing activities	(107,538,699)	(3,238,411)
Financing activities
Proceeds from issuance of debt	606,453	4,221,130
Payment of debt issuance costs		(91,620)
Repayment of term debt	(272,102)	(70,826)
Proceeds from the issuance of common stock, net	119,120,437	104,625,615
Proceeds from the exercise of stock options and warrants	1,723,846	2,318,709
Net cash provided by financing activities	121,178,634	111,003,008
Effect of exchange rate changes on cash, cash equivalents and restricted cash	36,152	(23,360)
Net change in cash, cash equivalents and restricted cash	(6,796,172)	93,452,416
Cash, cash equivalents and restricted cash at beginning of period	96,251,160	2,798,744
Cash, cash equivalents and restricted cash at end of period	89,454,988	96,251,160
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheet:
Cash and cash equivalents	88,454,988	95,751,160
Restricted cash	1,000,000	500,000
Supplemental disclosure of cash flow information and non-cash transactions:
Interest paid in cash	299,056	114,893
Property and equipment included in accounts payable and accrued liabilities	$ 2,926,016	$ 23,600

Nature of Business and Organiza

Nature of Business and Organization	12 Months Ended
	Dec. 31, 2021
Nature of Business and Organization [Abstract]
Nature of Business and Organization	1. Nature of business and organization Nature of businessAquaBounty Technologies, Inc. (the “Parent” and, together with its wholly owned subsidiaries, the “Company”) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm‑raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon. In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (“GE Atlantic salmon”) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.Basis of presentationThe consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the “Company.” All inter-company transactions and balances have been eliminated upon consolidation.LiquidityThe Company completed an equity raise in 2021with net proceeds of $119.1 million and has $191.2 million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company's requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of significant accounting policies Use of estimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Comprehensive lossThe Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company’s marketable securities. Foreign currency translationThe functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders’ equity.Cash equivalentsThe Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts. Marketable securitiesMarketable securities include government bonds, corporate bonds and commercial paper. The Company's investment policy requires investments to be explicitly rated by two of Standard & Poor's, Moody's or Fitch and to have a minimum rating of A1, P1 or F-1, respectively, from those agencies. In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.InventoriesInventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques. The Company measures inventory at the lower of cost or net realizable value (NRV). The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation. Intangible assetsDefinite lived intangible assets include patents and licenses. Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight-line basis over 20 years beginning with the filing date of the applicable patent. License fees are capitalized and expensed over the term of the licensing agreement.Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.Property, plant and equipmentProperty, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows: Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years The Company commences depreciation on an asset when it is placed into service.Impairment of long-lived assetsThe Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The Company’s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect to revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An impairment loss is recognized in the amount of the difference between the carrying amount and fair value.LeasesThe Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term. The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component. The Company adopted Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company’s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.Revenue recognitionThe Company generates revenue from the sale of its products. Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits. During 2021, the Company recognized $747 thousand and $428 thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.Income taxesThe Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company’s tax returns are required to be evaluated to determine whether the tax positions are “more likely than not” to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018. Net loss per shareBasic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.As of December 31, 2021, the Company had 1,081,866 potentially dilutive securities outstanding, consisting of 418,441 warrants and 663,425 stock options. As of December 31, 2020, the Company had 2,236,229 potentially dilutive securities outstanding, consisting of 1,662,304 warrants and 573,925 stock options.Share-based compensationThe Company measures and recognizes all share-based payment awards, including stock options and restricted share units made to employees and Directors, based on estimated fair values. The fair value of a share-based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company’s consolidated statement of operations. The Company uses the Black-Scholes option pricing model (“Black-Scholes”) as its method of valuation. Non-employee stock-based compensation is accounted for using Black-Scholes to determine the fair value of warrants or options awarded to non-employees with the fair value of such issuances expensed over the period of service.Recently Issued Accounting StandardsThe Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. The Company will remain an “emerging growth company” until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (“SEC”), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.

Risks and Uncertainties

Risks and Uncertainties	12 Months Ended
	Dec. 31, 2021
Risks and Uncertainties [Abstract]
Risks and Uncertainties	3. Risks and uncertainties The Company is subject to risks and uncertainties common in the biotechnology and aquaculture industries. Such risks and uncertainties include, but are not limited to: (i) results from current and planned product development studies and trials; (ii) decisions made by the FDA or similar regulatory bodies in other countries with respect to approval and commercial sale of any of the Company’s proposed products; (iii) the commercial acceptance of any products approved for sale and the Company’s ability to produce, distribute, and sell for a profit any products approved for sale; (iv) the Company’s ability to obtain the necessary patents and proprietary rights to effectively protect its technologies; and (v) the outcome of any collaborations or alliances entered into by the Company.COVID-19Although the COVID-19 pandemic has diminished in the United States and other parts of the world as vaccines have become more readily available, several variants of the virus continue to spread. Local governmental authorities in the United States and Canada have issued, and continue to update, directives aimed at minimizing the spread of the virus and the Company continues to monitor its status.The ultimate impact of the evolving COVID-19 pandemic on the Company’s operations will depend on future developments, which cannot be predicted with confidence, and the Company cannot predict the extent or impact of the extended period of continued business interruption and reduced operations caused by the COVID-19 pandemic or any additional preventative or protective measures taken in response. In connection with the COVID-19 pandemic, management made modifications to biosecurity procedures at the farm sites in early 2020 to adapt to local requirements and to provide a safe work environment. The Company’s current preventative and protective measures include, but are not limited to, segregating farm workers to specific locations, rotating shifts, and monitoring worker temperatures upon arrival at the Company’s facilities. To the extent possible, work-from-home is utilized for employees that do not have fish care responsibilities. Concentration of credit riskFinancial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. This risk is mitigated by the Company’s policy of maintaining all balances with highly rated financial institutions, investing cash equivalents with maturities of less than 90 days, and investing marketable securities with maturities of less than 180 days. The Company’s cash balances may at times exceed insurance limitations. The Company holds cash balances in bank accounts located in Canada to fund its local operations. These amounts are subject to foreign currency exchange risk, which is minimized by the Company’s policy to limit the balances held in these accounts. Balances in Canadian bank accounts totaled $224 thousand at December 31, 2021. The Company also holds cash equivalent investments in a highly liquid investment account at a major financial institution. As of December 31, 2021 and 2020 the cash equivalent investment balance was $73.3 million and $0, respectively.Financial instrumentsThe carrying amounts reported in the consolidated balance sheets for receivables, prepaid expenses and other current assets, and accounts payable approximate fair value based on the short-term maturity of these instruments. The carrying value of term debt approximates its fair value since it provides for market terms and interest rates. All of the Company’s interest-bearing debt is at fixed rates, except for the loan with First Farmer’s Bank and Trust, which has a rate reset in July 2025.The Company groups its financial instruments measured at fair value, if any, in three levels based on the markets in which the instruments are traded and the reliability of the assumptions used to determine fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial instruments with readily available quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgement used in measuring fair value. The three levels of the fair value hierarchy are as follows:Level 1: Inputs to the valuation methodology are quoted prices, unadjusted, for identical assets or liabilities in active markets. Level 2: Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs derived principally from, or that can be corroborated by, observable market data by correlation or other means.Level 3: Inputs to the valuation methodology are unobservable and significant to the fair value measurement. Level 3 assets and liabilities include financial instruments whose value is determined using discounted cash flow methodologies, as well as instruments for which the determination of fair value requires significant management judgement or estimation.

Marketable Securities

Marketable Securities	12 Months Ended
	Dec. 31, 2021
Marketable Securities [Abstract]
Marketable Securities	4. Marketable SecuritiesMarketable securities are classified as available-for-sale. The following table summarizes the amortized cost, gross unrealized gains and losses, and the fair value as of December 31, 2021: Amortized Unrealized Unrealized Market Cost Gains Losses Value December 31, 2021Government bonds$ 28,453,161 $ 82 $ (18,255) $ 28,434,988Corporate bonds 29,874,696 - (21,928) 29,852,768Commercial paper 43,486,025 - - 43,486,025Marketable securities$ 101,813,882 $ 82 $ (40,183) $ 101,773,781There were no marketable securities as of December 31, 2020.

Inventory

Inventory	12 Months Ended
	Dec. 31, 2021
Inventory [Abstract]
Inventory	5. Inventory Major classifications of inventory are summarized as follows for December 31, 2021 and 2020: December 31, 2021 December 31, 2020Feed, net$ 162,047 244,311Eggs and fry — 54,929Packaging — 6,452Fish in process, net 1,097,863 1,219,685Inventory, net$ 1,259,910 1,525,377 In December 2020, the Company reserved $1.53 million against the value of its fish-in-process inventory, representing the total carrying amount of its conventional salmon biomass. The Company donated substantially all of its conventional salmon to local food charities in 2021.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	6. Property, plant and equipment Major classifications of property, plant and equipment are summarized as follows for December 31, 2021 and 2020: December 31, 2021 December 31, 2020Land$ 725,799 $ 724,785Building and improvements 15,580,385 14,048,917Construction in process 8,119,575 3,212,287Equipment 15,981,408 13,819,210Office furniture and equipment 240,939 202,596Vehicles 36,280 28,700Total property and equipment$ 40,684,386 $ 32,036,495Less accumulated depreciation and amortization (6,869,267) (5,106,157)Property, plant and equipment, net$ 33,815,119 $ 26,930,338 Depreciation and amortization expense for 2021 and 2020 on property, plant and equipment was $1.8 million and $1.5 million, respectively. In March 2020, the Company settled an outstanding legal claim against a third party resulting in net proceeds of $1.0 million. The proceeds received reduced the carrying value of the acquired equipment. Depreciation on these items has been recalculated prospectively over their remaining useful lives. As of December 31, 2021, construction in process included $5.2 million, $2.0 million and $856 thousand for construction related to the Ohio, Rollo Bay and Indiana farm sites, respectively. An additional $12.2 million has been contractually committed for these farm sites, though if a contract were terminated, a portion of this total would be refundable based on the amount of work completed as of the date of contract termination.

Debt

Debt	12 Months Ended
	Dec. 31, 2021
Debt [Abstract]
Debt	7. Debt The current terms and conditions of long-term debt outstanding as of December 31, 2021 and 2020, are as follows: Interest‎rate Monthly‎repayment Maturity‎date December 31, 2021 December 31, 2020ACOA AIF Grant 0% Royalties - $ 2,261,349 $ 2,253,595ACOA term loan #1 0% C$3,120 Feb 2027 152,346 181,203ACOA term loan #2 0% C$4,630 Sep 2029 339,015 381,451ACOA term loan #3 0% C$6,945 Dec 2025 196,850 —Kubota Canada Ltd 0% C$1,142 Jan 2025 33,283 43,925PEI Finance term loan 4% C$16,313 Nov 2023 1,947,510 2,014,321DFO term loan 0% C$2,091 Aug 2032 405,700 —First Farmers Bank & Trust term loan 5.375% $56,832 Oct 2028 3,883,325 4,000,000Total debt $ 9,219,378 $ 8,874,495less: debt issuance costs (68,680) (86,066)less: current portion (627,365) (259,939)Long-term debt, net $ 8,523,333 $ 8,528,490 Principal payments due on the long-term debt are as follows: Total2022$ 643,9802023 2,564,3472024 729,6262025 750,1752026 715,392Thereafter 3,815,858Total$ 9,219,378 Atlantic Canada Opportunities Agency (“ACOA”)ACOA is a Canadian government agency that provides funding to support the development of businesses and promote employment in the Atlantic region of Canada.ACOA Atlantic Innovation Fund (“AIF”) GrantIn January 2009, the Canadian Subsidiary was awarded an AIF grant from ACOA to provide a contribution towards the funding of a research and development project. Contributions under the grant were made through 2014 and no further funds are available. Amounts claimed by the Canadian Subsidiary must be repaid in the form of a 10% royalty on any products that are commercialized out of this research project until the loan is fully repaid. Revenue from the sale of the Company’s GE Atlantic salmon is not subject to the royalty, and the Company does not expect to commercialize products that would be subject to the royalty in the next five years.ACOA term loansIn February 2016, the Canadian Subsidiary executed an agreement with ACOA to partially finance the renovations to the Rollo Bay farm site. All available funding under the agreement was disbursed through May 2017, and no further amounts are available. The loan is being repaid over a 108-month term at a zero percent interest rate. In November 2018, the Canadian Subsidiary executed a second agreement with ACOA to partially finance the renovations to the Rollo Bay site. All available funding under the agreement was disbursed through March 2019, and no further amounts are available. The loan is being repaid over a 108-month term with a zero percent interest rate. In response to the COVID-19 pandemic, the Company was informed by ACOA during 2020, that all loan payments to the Canadian government would be deferred for nine months and resume on January 1, 2021.In July 2021, the Canadian Subsidiary entered into a contribution agreement with ACOA under its REGI-Business Scale-up and Productivity program to provide funding assistance for the Rollo Bay farm site, and on August 20, 2021, the Canadian Subsidiary received C$250,000 ($200,075). All funds received are to be repaid over a 36-month term commencing January 2023 at a zero percent interest rate.KubotaIn January 2018, the Canadian Subsidiary financed the purchase of equipment through a loan with Kubota. The total amount is being repaid in monthly installments. The loan is secured by the underlying equipment.Finance PEI (“FPEI”)FPEI is a corporation of the Ministry of Economic Development and Tourism for Prince Edward Island, Canada, and administers business financing programs for the provincial government.In August 2016, the Canadian Subsidiary obtained a loan from FPEI to partially finance the purchase of the assets of the former Atlantic Sea Smolt plant in Rollo Bay West on Prince Edward Island.In 2018, the Canadian Subsidiary obtained a new loan from FPEI, which incorporated the existing loan and provided C$2.0 million ($1.5 million) of additional funds. All funds have been dispersed and the loan is being repaid over an 87-month term ending in November 2023. The loan has an interest rate of 4% and is collateralized by a mortgage executed by the Canadian Subsidiary, which conveys a first security interest in all of its current and acquired assets. The loan is guaranteed by the Parent.On March 24, 2020, the Company was informed by FPEI that all payments would be deferred for three months due to the COVID-19 pandemic. Payments on the loan resumed on August 1, 2020.First Farmers Bank & Trust (“FFBT”)On July 31, 2020, the Company’s Indiana Subsidiary obtained a $4.0 million loan from First Farmers Bank and Trust. Net proceeds were $3.9 million after deducting $90 thousand in loan costs. The loan bears interest at a rate of 5.375% for the first five years. On July 31, 2025, the interest rate resets to the then U.S. Treasury 5-year maturities rate plus 5% and remains fixed at that rate through maturity on October 1, 2028. The note required interest only payments for the first 13 months, followed by monthly principal and interest payments of approximately $57 thousand through maturity. Proceeds from the loan may be used for the purpose of performing equipment upgrades, purchasing equipment and other improvements to the Indiana farm. The Company must comply with certain financial and non-financial covenants and provide certification of compliance quarterly. At December 31, 2021, the Company was in compliance with such covenants. The loan is also subject to certain prepayment penalties and is secured by the assets of the Indiana subsidiary and a guarantee by the Parent. The loan agreement requires the Company to maintain a minimum cash balance with the bank throughout the loan term. This amount is reflected as restricted cash on the balance sheet.On October 12, 2021, the Company and First Farmers Bank & Trust agreed to a modification to the terms of its outstanding loan. The new terms delay the start date of certain of the loan’s negative covenants to the quarter commencing on October 1, 2022 and raises the required restricted cash balance amount from $500 thousand to $1.0 million. Department of Fisheries and Oceans (“DFO”)DFO is a department of the government of Canada responsible for safeguarding its waters and managing its fisheries, oceans and freshwater resources. DFO supports economic growth in the marine and fisheries sectors, and innovation in areas such as aquaculture and biotechnology.In September 2020, the Canadian Subsidiary entered into a Contribution Agreement with DFO's Atlantic Fisheries Fund, whereby it is eligible to receive up to C$1.9 million ($1.4 million) to finance new equipment for its Rollo Bay farm (the “DFO Term Loan”). On February 25, 2021, the Canadian Subsidiary borrowed C$238,400 ($187,120) and on April 27, 2021 the Canadian Subsidiary borrowed C$276,840 ($219,258) under the DFO Term Loan. Borrowings are interest free and monthly repayments commence in March 2023, with maturity in August 2032. All funding requests must be submitted by August 22, 2022.The Company recognized interest expense of $316 thousand and $152 thousand for the years ended December 31, 2021 and 2020, respectively, on its interest-bearing debt.

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity [Abstract]
Stockholders' Equity	8. Stockholders’ equity The Company’s shareholders have authorized 85 million shares of stock, of which 5 million are authorized as preferred stock and 80 million as common stock. As of December 31, 2021 and 2020, the Company had zero shares of preferred stock and 71,025,738 shares and 55,497,133 shares of common stock, issued and outstanding, respectively.Common stockThe holders of the common stock are entitled to one vote for each share held at all meetings of stockholders. Dividends and distribution of assets of the Company in the event of liquidation are subject to the preferential rights of any outstanding preferred shares.Recent issuancesDuring 2020, the Company completed a series of public offerings, resulting in the aggregate issuance of 33,028,000 shares of common stock for net proceeds of approximately $104.6 million.During 2021, the Company completed a public offering of 14,950,000 shares of common stock for net proceeds of approximately $119.1 million. WarrantsThe following table summarizes information about outstanding warrants as of December 31, 2021: Number of ‎options Weighted‎average‎exercise priceOutstanding at December 31, 2020 948,855 $ 3.25Issued — -Exercised (530,414) 3.25Expired — -Outstanding at December 31, 2021 418,441 3.25Exercisable at December 31, 2021 418,441 3.25 All remaining warrants have an expiration date of January 17, 2023.Share-based compensationIn 2006, the Company established the 2006 Equity Incentive Plan (the “2006 Plan”). The 2006 Plan provided for the issuance of incentive stock options to employees of the Company and non-qualified stock options and awards of restricted stock to Directors, officers, employees, and consultants of the Company. In accordance with its original terms, the 2006 Plan terminated on March 18, 2016. All outstanding awards under the 2006 Plan will continue until their individual termination dates.In March 2016, the Company’s Board of Directors adopted the AquaBounty Technologies, Inc. 2016 Equity Incentive Plan (the “2016 Plan”) to replace the 2006 Plan. The 2016 Plan provides for the issuance of incentive stock options, non-qualified stock options, and awards of restricted and direct stock purchases to Directors, officers, employees, and consultants of the Company. Total common shares authorized under the 2016 Plan were 1,900,000, of which 916,516 shares are reserved for future issuance as of December 31, 2021. Restricted stockThe Company’s restricted stock activity under the 2016 Plan is summarized as follows: Shares Weighted‎average grant‎date fair valueBalance at December 31, 2020 92,653 $ 1.93Granted 43,837 6.67Vested (71,390) 2.86Balance at December 31, 2021 65,100 $ 4.10 During 2021 and 2020, the Company expensed $240 thousand and $227 thousand, respectively related to restricted stock awards. At December 31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to the restricted stock awards is $147 thousand. The period over which the unearned share-based compensation is expected to be earned is approximately 2.2 years.Stock optionsThe Company’s option activity under the 2006 Plan and the 2016 Plan is summarized as follows: Number of ‎options Weighted‎average‎exercise priceOutstanding at December 31, 2020 657,414 $ 4.28Granted 48,914 6.72Exercised (16,667) 6.90Forfeited (1,959) 6.72Expired (24,277) 6.36Outstanding at December 31, 2021 663,425 $ 4.31Exercisable at December 31, 2021 607,189 $ 4.33 Options issued to employees, members of the Board of Directors, and non-employees generally vest over a period of one year to three years and are exercisable for a term of ten years from the date of issuance.The weighted average fair value of stock options granted during 2021 was $5.36 (2020: $1.49). There were 16,667 options exercised in 2021 (2020: zero). The total intrinsic value of options exercised in 2021 was $41 thousand (2020: $0). As of December 31, 2021, the total intrinsic value of all options outstanding was $18 thousand (2020: $3.6 million) and the total intrinsic value of exercisable options was $11 thousand (2020: $3.2 million).The following table summarizes information about options outstanding and exercisable as of December 31, 2021: Weighted‎average exercise‎price of outstanding‎options Number of‎options‎outstanding Weighted‎average remaining‎estimated life‎(in years) Number of‎options‎exercisable $1.88 - $2.50 524,019 7.3 493,772 $3.30 - $6.72 53,916 8.4 27,927 $7.50 - $10.80 16,403 2.3 16,403 $14.20 - $23.40 69,087 4.2 69,087 663,425 607,189 The fair values of stock option grants to employees and members of the Board of Directors during 2021 and 2020 were measured on the date of grant using Black-Scholes, with the following weighted average assumptions: 20212020Expected volatility 111%101%-104%Risk free interest rate 0.80%0.31%-1.67%Expected dividend yield 0%0%Expected life (in years) 55 The risk-free interest rate is estimated using the Federal Funds interest rate for a period that is commensurate with the expected term of the awards. The expected dividend yield is zero because the Company has never paid a dividend and does not expect to do so for the foreseeable future. The expected life was based on a number of factors including historical experience, vesting provisions, exercise price relative to market price, and expected volatility. The Company believes that all groups of employees demonstrate similar exercise and post-vesting termination behavior and, therefore, does not stratify employees into multiple groups and forfeitures are recognized as they occur. The expected volatility was estimated using the Company’s historical price volatility over a period that is commensurate with the expected term of the awards.Total share-based compensation on stock-option grants amounted to $154 thousand and $251 thousand for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021, the balance of unearned share-based compensation to be expensed in future periods related to unvested share-based awards is $182 thousand. The period over which the unearned share-based compensation is expected to be earned is 2.2 years.Share-based compensationThe following table summarizes share-based compensation costs recognized in the Company’s Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2021 and 2020: 2021 2020Research and development $ - $ 497General and administrative 394,237 436,194Total share-based compensation $ 394,237 $ 436,691

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Income Taxes	9. Income taxes The components of loss before income taxes for the years ended December 31, 2021 and 2020 are presented below: 2021 2020Domestic$ (21,105,065) $ (15,768,224)Foreign (1,217,523) (631,761)Loss before income taxes$ (22,322,588) $ (16,399,985) We have made no provision for foreign or domestic income taxes on the cumulative unremitted earnings of our foreign subsidiaries. We intend to permanently reinvest all foreign earnings and have no intention to repatriate foreign earnings for the foreseeable future. Income taxes computed using the federal statutory income tax rate differs from the Company’s effective tax rate for the years ended December 31, 2021 and 2020 primarily due to the following: 2021 2020Income tax benefit$ (4,687,744) $ (3,443,997)State and provincial income tax, net of federal benefit (1,157,840) (732,994)Permanent differences 202,583 131,141US-Foreign rate differential 39,045 (142,663)Other, net (299,071) (145,973) $ (5,903,027) $ (4,334,486)Change in valuation allowance 5,903,027 4,334,486Total income tax$ - $ - As of December 31, 2021, the Company has domestic net operating loss carryforwards of approximately $78 million, after consideration of limitations pursuant to section 382, to offset future federal taxable income, which begin to expire in 2032. As of December 31, 2021, the Company has domestic net operating loss carryforwards of approximately $50 million, which can be carried forward indefinitely. The future utilization of certain historic net operating loss and tax credit carryforwards, however, is subject to annual use limitations based on the change in stock ownership rules of Internal Revenue Code Sections 382 and 383. The Company experienced a change in ownership under these rules during 2012 and revised its calculation of net operating loss carryforwards based on annual limitation rules. The Company also has foreign research and development loss carryforwards totaling approximately $11 million and foreign research and development expense tax credits of approximately $2 million as of December 31, 2021, which expire at various times commencing in 2022. Since the Company has incurred only losses from inception and there is uncertainty related to the ultimate use of the loss carryforwards and tax credits, a valuation allowance has been recognized to offset the Company’s deferred tax assets, and no benefit for income taxes has been recorded.Significant components of the Company’s deferred tax assets and liabilities are as follows: 2021 2020Deferred tax assets: Net operating loss carryforwards$ 23,216,863 $ 16,964,199Foreign research and development tax credit carryforwards 2,428,663 2,679,180Property and equipment 145,530 56,697Intangibles and other 2,934,441 3,122,394Total deferred tax assets$ 28,725,497 $ 22,822,470Valuation allowance$ (28,725,497) $ (22,822,470)Net deferred tax assets$ - $ -

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies [Abstract]
Commitments and Contingencies	10. Commitments and contingencies The Company recognizes and discloses commitments when it enters into executed contractual obligations with other parties. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.The Company is subject to legal proceedings and claims arising in the normal course of business. Management believes that final disposition of any such matters existing at December 31, 2021, will not have a material adverse effect on the Company’s financial position or results of operations.Lease commitmentsLease expense for the years ended December 31, 2021 and 2020, amounted to $84 thousand and $86 thousand, respectively. As of December 31, 2021, the weighted average remaining lease term of the Company’s operating leases was 24.1 years. Lease payments included in operating cash flows totaled $84 thousand and $85 thousand for the years ended December 31, 2021 and 2020, respectively. The table below summarizes the Company’s lease obligations as of December 31, 2021 and 2020: December 31, 2021 December 31, 2020 Lease Liability Lease LiabilityTotal leases$ 290,327 $ 352,810Less: current portion (66,269) (62,483)Long-term leases$ 224,058 $$ 290,327 The Company used a weighted average discount rate of 8% in calculating the net present value of the future lease payments. The current portion of the lease liability is included as a component of other current liabilities in the consolidated balance sheets.Remaining payments under leases are as follows as of December 31, 2021: Year Amount2022 $ 84,0802023 33,8722024 17,4812025 18,0062026 18,546Thereafter 583,328Total lease payments 755,313Less: imputed interest (464,986)Total operating lease liabilities $ 290,327

Retirement Plan

Retirement Plan	12 Months Ended
	Dec. 31, 2021
Retirement Plan [Abstract]
Retirement Plan	11. Retirement plan The Company has a savings and retirement plan for its US employees that qualifies under Section 401(k) of the Internal Revenue Code. The plan covers substantially all employees and provides for voluntary contributions by participating employees up to the maximum contribution allowed under the Internal Revenue Code. Contributions by the Company can be made, as determined by the Board of Directors, provided the amount does not exceed the maximum permitted by the Internal Revenue Code. Company contributions made and expensed in operations in connection with the plan during the years ended December 31, 2021 and 2020, amounted to $81 thousand and $72 thousand, respectively.The Company also has a Registered Retirement Savings Plan for its Canadian employees. Company contributions made and expensed in operations in connection with the plan during the years ended December 31, 2021 and 2020, amounted to $38 thousand and $32 thousand, respectively.

Related Party Agreement

Related Party Agreement	12 Months Ended
	Dec. 31, 2021
Related Party Agreement [Abstract]
Related Party Agreement	12. Related Party Agreement Letter Agreement with Third SecurityOn July 30, 2021, the Company entered into an agreement with TS Aquaculture LLC and certain of its affiliates (“TS Aquaculture”) that required the Company to file a registration statement to register the Company’s shares held by TS Aquaculture. The registration statement was filed on August 5, 2021 and TS Aquaculture completed a transaction to sell 12,880,000 shares of common stock of the Company on November 23, 2021. TS Aquaculture ceased being a related party after completing the sale. TS Aquaculture agreed to pay all expenses incurred in connection with these transactions, which totaled $418 thousand and is included in prepaid and other current assets in the consolidated financial statements as of December 31, 2021.

Nature of Business and Organi_2

Nature of Business and Organization (Policy)	12 Months Ended
	Dec. 31, 2021
Nature of Business and Organization [Abstract]
Nature of Business	Nature of businessAquaBounty Technologies, Inc. (the “Parent” and, together with its wholly owned subsidiaries, the “Company”) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm‑raised Atlantic salmon that exhibit growth rates that are substantially faster than conventional salmon. In 2015, the Parent obtained regulatory approval from the U.S. Food and Drug Administration for the production and sale of its genetically engineered AquAdvantage salmon product (“GE Atlantic salmon”) in the United States and in 2016, the Parent obtained regulatory approval from Health Canada for the production and sale of its GE Atlantic salmon product in Canada. In 2021, the Parent obtained regulatory approval from the National Biosafety Technical Commission for the sale of its GE Atlantic salmon product in Brazil.
Basis of Presentation	Basis of presentationThe consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned subsidiaries. The entities are collectively referred to herein as the “Company.” All inter-company transactions and balances have been eliminated upon consolidation.
Liquidity	LiquidityThe Company completed an equity raise in 2021with net proceeds of $119.1 million and has $191.2 million in cash and cash equivalents, marketable securities and restricted cash as of December 31, 2021. While the Company has experienced net losses and negative cash flows from operations since inception, management believes that it has sufficient cash to meet the Company's requirements beyond the next twelve months from the filing date of these consolidated financial statements. However, until such time as the Company reaches profitability, it may require additional financing to fund its operations and execute its business plan.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Use of Estimates	Use of estimatesThe preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the consolidated financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.
Comprehensive Loss	Comprehensive lossThe Company displays comprehensive loss and its components as part of its consolidated financial statements. Comprehensive loss consists of net loss and other comprehensive income (loss). Other comprehensive income (loss) includes foreign currency translation adjustments and unrealized gains (losses) on the Company’s marketable securities.
Foreign Currency Translation	Foreign currency translationThe functional currency of the Parent is the US Dollar. The functional currency of the Canadian Subsidiary is the Canadian Dollar (C$) and the functional currency of the US and Brazil Subsidiaries is the US Dollar. For the Canadian Subsidiary, assets and liabilities are translated at the exchange rates in effect at the balance sheet date, equity accounts are translated at the historical exchange rate and the income statement accounts are translated at the average rate for each period during the year. Net translation gains or losses are adjusted directly to a separate component of other comprehensive income (loss) within stockholders’ equity.
Cash Equivalents	Cash equivalentsThe Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash equivalents consist primarily of business savings accounts, certificates of deposit and money market accounts.
Marketable Securities	Marketable securitiesMarketable securities include government bonds, corporate bonds and commercial paper. The Company's investment policy requires investments to be explicitly rated by two of Standard & Poor's, Moody's or Fitch and to have a minimum rating of A1, P1 or F-1, respectively, from those agencies. In addition, the investment policy limits individual maturities to 12 months, the dollar-weighted average maturity to 180 days and the amount of credit exposure to any one issuer to 5%.
Inventories	InventoriesInventories are mainly comprised of feed, eggs and fish in process. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques. The Company measures inventory at the lower of cost or net realizable value (NRV). The NRV calculation contains various estimates and assumptions in regard to the calculation of the biomass, including expected yield, the market value of the biomass and estimated costs of completion and transportation.
Intangible Assets	Intangible assetsDefinite lived intangible assets include patents and licenses. Patent costs consist primarily of legal and filing fees incurred to file patents on proprietary technology developed by the Company. Patent costs are amortized on a straight-line basis over 20 years beginning with the filing date of the applicable patent. License fees are capitalized and expensed over the term of the licensing agreement.Indefinite lived intangible assets include trademark costs, which are capitalized with no amortization as they have an indefinite life.
Property, Plant and Equipment	Property, plant and equipmentProperty, plant and equipment are carried at cost. The Company depreciates all asset classes over their estimated useful lives, as follows: Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years The Company commences depreciation on an asset when it is placed into service.
Impairment of Long-lived Assets	Impairment of long-lived assetsThe Company reviews the carrying value of its long-lived assets, definite lived intangible assets, and property, plant and equipment when facts and circumstances suggest that they may be impaired. The carrying values of such assets are considered impaired when the estimated undiscounted cash flows from such assets are less than their carrying values. An impairment loss, if any, is recognized in the amount of the difference between the carrying amount and the fair value of such assets.Indefinite lived intangible assets are subject to impairment testing annually or more frequently if impairment indicators arise. The Company’s impairment testing utilizes a discounted cash flow analysis that requires significant management judgment with respect to revenue and expense growth rates, changes in working capital and the selection and use of the appropriate discount rate. An impairment loss is recognized in the amount of the difference between the carrying amount and fair value.
Leases	LeasesThe Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term. The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component. The Company adopted Financial Accounting Standards Board's (FASB) Accounting Standards Update (ASU) 2016-02 Leases on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company’s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.
Revenue Recognition	Revenue recognitionThe Company generates revenue from the sale of its products. Revenue is recognized when the customer takes physical control of the goods, in an amount that reflects the transaction price consideration that the Company expects to receive in exchange for the goods. Revenue excludes any sales tax collected and includes any estimate of future credits. During 2021, the Company recognized $747 thousand and $428 thousand in revenue from product sales from its Canada and U.S. subsidiaries, respectively.
Income Taxes	Income taxesThe Company uses the liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are recorded for the expected future tax consequences of temporary differences between the financial reporting and income tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences reverse. A valuation allowance is established to reduce net deferred tax assets to the amount expected to be realized. The Company follows accounting guidance regarding the recognition, measurement, presentation and disclosure of uncertain tax positions in the financial statements. Tax positions taken or expected to be taken in the course of preparing the Company’s tax returns are required to be evaluated to determine whether the tax positions are “more likely than not” to be upheld under regulatory review. The resulting tax impact of these tax positions is recognized in the financial statements based on the results of this evaluation. The Company did not recognize any tax liabilities associated with uncertain tax positions, nor has it recognized any interest or penalties related to unrecognized tax positions. The Company is not currently under exam and is no longer subject to federal and state tax examinations by tax authorities for years before 2018.
Net Loss Per Share	Net loss per shareBasic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the year. Basic net loss per share is based solely on the number of common shares outstanding during the year. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and options with an exercise price less than the fair value of the common stock unless the impact of the warrant or option is anti-dilutive to the calculation. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti-dilutive and are excluded from the calculation of diluted net loss per share.As of December 31, 2021, the Company had 1,081,866 potentially dilutive securities outstanding, consisting of 418,441 warrants and 663,425 stock options. As of December 31, 2020, the Company had 2,236,229 potentially dilutive securities outstanding, consisting of 1,662,304 warrants and 573,925 stock options.
Share-based Compensation	Share-based compensationThe Company measures and recognizes all share-based payment awards, including stock options and restricted share units made to employees and Directors, based on estimated fair values. The fair value of a share-based payment award is estimated on the date of grant using an option pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service period in the Company’s consolidated statement of operations. The Company uses the Black-Scholes option pricing model (“Black-Scholes”) as its method of valuation. Non-employee stock-based compensation is accounted for using Black-Scholes to determine the fair value of warrants or options awarded to non-employees with the fair value of such issuances expensed over the period of service.
Recently Issued Accounting Standards	Recently Issued Accounting StandardsThe Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act, and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. The Company has elected to use the extended transition period for complying with new or revised accounting standards unless otherwise state. The Company will remain an “emerging growth company” until the earliest of (i) December 31, 2023, (ii) the last day of the fiscal year in which it has total annual gross revenues of $1.07 billion or more, (iii) the date on which it has issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which it is deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission (“SEC”), which generally is when it has more than $700 million in market value of its stock held by non-affiliates, has been a public company for at least 12 months and have filed one annual report on Form 10-K.Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies [Abstract]
Property, Plant and Equipment Estimated Useful Lives	Building 20 - 25 yearsEquipment 5 - 20 yearsOffice furniture and equipment 3 yearsLeasehold improvements shorter of asset life or lease termVehicles 3 years

Marketable Securities (Tables)

Marketable Securities (Tables)	12 Months Ended
	Dec. 31, 2021
Marketable Securities [Abstract]
Schedule of Marketable Securities	Amortized Unrealized Unrealized Market Cost Gains Losses Value December 31, 2021Government bonds$ 28,453,161 $ 82 $ (18,255) $ 28,434,988Corporate bonds 29,874,696 - (21,928) 29,852,768Commercial paper 43,486,025 - - 43,486,025Marketable securities$ 101,813,882 $ 82 $ (40,183) $ 101,773,781

Inventory (Tables)

Inventory (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory [Abstract]
Schedule of Inventory	December 31, 2021 December 31, 2020Feed, net$ 162,047 244,311Eggs and fry — 54,929Packaging — 6,452Fish in process, net 1,097,863 1,219,685Inventory, net$ 1,259,910 1,525,377

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	December 31, 2021 December 31, 2020Land$ 725,799 $ 724,785Building and improvements 15,580,385 14,048,917Construction in process 8,119,575 3,212,287Equipment 15,981,408 13,819,210Office furniture and equipment 240,939 202,596Vehicles 36,280 28,700Total property and equipment$ 40,684,386 $ 32,036,495Less accumulated depreciation and amortization (6,869,267) (5,106,157)Property, plant and equipment, net$ 33,815,119 $ 26,930,338

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt [Abstract]
Terms and Conditions of Long-term Debt Outstanding	Interest‎rate Monthly‎repayment Maturity‎date December 31, 2021 December 31, 2020ACOA AIF Grant 0% Royalties - $ 2,261,349 $ 2,253,595ACOA term loan #1 0% C$3,120 Feb 2027 152,346 181,203ACOA term loan #2 0% C$4,630 Sep 2029 339,015 381,451ACOA term loan #3 0% C$6,945 Dec 2025 196,850 —Kubota Canada Ltd 0% C$1,142 Jan 2025 33,283 43,925PEI Finance term loan 4% C$16,313 Nov 2023 1,947,510 2,014,321DFO term loan 0% C$2,091 Aug 2032 405,700 —First Farmers Bank & Trust term loan 5.375% $56,832 Oct 2028 3,883,325 4,000,000Total debt $ 9,219,378 $ 8,874,495less: debt issuance costs (68,680) (86,066)less: current portion (627,365) (259,939)Long-term debt, net $ 8,523,333 $ 8,528,490
Principal Payments Due on Long-term Debt	Total2022$ 643,9802023 2,564,3472024 729,6262025 750,1752026 715,392Thereafter 3,815,858Total$ 9,219,378

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Stockholders' Equity [Abstract]
Information About Outstanding Warrants	Number of ‎options Weighted‎average‎exercise priceOutstanding at December 31, 2020 948,855 $ 3.25Issued — -Exercised (530,414) 3.25Expired — -Outstanding at December 31, 2021 418,441 3.25Exercisable at December 31, 2021 418,441 3.25
Restricted Stock Activity	Shares Weighted‎average grant‎date fair valueBalance at December 31, 2020 92,653 $ 1.93Granted 43,837 6.67Vested (71,390) 2.86Balance at December 31, 2021 65,100 $ 4.10
Stock Option Activity	Number of ‎options Weighted‎average‎exercise priceOutstanding at December 31, 2020 657,414 $ 4.28Granted 48,914 6.72Exercised (16,667) 6.90Forfeited (1,959) 6.72Expired (24,277) 6.36Outstanding at December 31, 2021 663,425 $ 4.31Exercisable at December 31, 2021 607,189 $ 4.33
Information About Options Outstanding and Exercisable	Weighted‎average exercise‎price of outstanding‎options Number of‎options‎outstanding Weighted‎average remaining‎estimated life‎(in years) Number of‎options‎exercisable $1.88 - $2.50 524,019 7.3 493,772 $3.30 - $6.72 53,916 8.4 27,927 $7.50 - $10.80 16,403 2.3 16,403 $14.20 - $23.40 69,087 4.2 69,087 663,425 607,189
Stock Option Grants Weighted Average Assumptions	20212020Expected volatility 111%101%-104%Risk free interest rate 0.80%0.31%-1.67%Expected dividend yield 0%0%Expected life (in years) 55
Share-based Compensation Costs Recognized on Financial Statements	2021 2020Research and development $ - $ 497General and administrative 394,237 436,194Total share-based compensation $ 394,237 $ 436,691

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Taxes [Abstract]
Components of Loss before Income Taxes	2021 2020Domestic$ (21,105,065) $ (15,768,224)Foreign (1,217,523) (631,761)Loss before income taxes$ (22,322,588) $ (16,399,985)
Schedule of Effective Income Tax Rate Reconciliation	2021 2020Income tax benefit$ (4,687,744) $ (3,443,997)State and provincial income tax, net of federal benefit (1,157,840) (732,994)Permanent differences 202,583 131,141US-Foreign rate differential 39,045 (142,663)Other, net (299,071) (145,973) $ (5,903,027) $ (4,334,486)Change in valuation allowance 5,903,027 4,334,486Total income tax$ - $ -
Components of Deferred Tax Assets and Liabilities	2021 2020Deferred tax assets: Net operating loss carryforwards$ 23,216,863 $ 16,964,199Foreign research and development tax credit carryforwards 2,428,663 2,679,180Property and equipment 145,530 56,697Intangibles and other 2,934,441 3,122,394Total deferred tax assets$ 28,725,497 $ 22,822,470Valuation allowance$ (28,725,497) $ (22,822,470)Net deferred tax assets$ - $ -

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies [Abstract]
Summary of Lease Obligations	December 31, 2021 December 31, 2020 Lease Liability Lease LiabilityTotal leases$ 290,327 $ 352,810Less: current portion (66,269) (62,483)Long-term leases$ 224,058 $$ 290,327
Summary of Remaining Payments under Leases	Year Amount2022 $ 84,0802023 33,8722024 17,4812025 18,0062026 18,546Thereafter 583,328Total lease payments 755,313Less: imputed interest (464,986)Total operating lease liabilities $ 290,327

Nature of Business and Organi_3

Nature of Business and Organization (Details) $ in Millions	Dec. 31, 2021USD ($)
Nature of Business and Organization [Abstract]
Additional cash and cash equivalents	$ 119.1
Cash, cash equivalents, marketable securities and restricted cash	$ 191.2

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2019
Lease liability	$ 290,327	$ 352,810	$ 532,000
Right of use assets	284,320	341,997	$ 512,000
Product revenues	$ 1,174,832	$ 127,663
Potentially dilutive securities outstanding (in shares)	1,081,866	2,236,229
Weighted Average [Member]
Discount rate			8.00%
Warrant [Member]
Potentially dilutive securities outstanding (in shares)	418,441	1,662,304
Stock Option [Member]
Potentially dilutive securities outstanding (in shares)	663,425	573,925
Patents [Member] | Minimum [Member]
Patents, useful life	20 years
Canada Subsidiary [Member]
Product revenues	$ 747,000
United States Subsidiary [Member]
Product revenues	$ 428,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Property, Plant and Equipment Estimated Useful Lives) (Details)	12 Months Ended
	Dec. 31, 2021
Building [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	20 years
Building [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	25 years
Equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	5 years
Equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	20 years
Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	3 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, useful life	shorter of asset life or lease term

Risks and Uncertainties (Detail

Risks and Uncertainties (Details) - Credit Concentration Risk [Member] - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Concentration Risk [Line Items]
Cash equivalent investment balance	$ 73,300	$ 0
Canada [Member]
Concentration Risk [Line Items]
Cash in Canadian bank accounts	$ 224

Marketable Securities (Schedule

Marketable Securities (Schedule of Marketable Securities) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Marketable Securities [Line Items]
Amortized cost	$ 101,813,882
Unrealized Gains	82
Unrealized Losses	(40,183)
Market Value	101,773,781	$ 0
Government Bonds [Member]
Marketable Securities [Line Items]
Amortized cost	28,453,161
Unrealized Gains	82
Unrealized Losses	(18,255)
Market Value	28,434,988
Corporate Bonds [Member]
Marketable Securities [Line Items]
Amortized cost	29,874,696
Unrealized Losses	(21,928)
Market Value	29,852,768
Commercial Paper [Member]
Marketable Securities [Line Items]
Amortized cost	43,486,025
Market Value	$ 43,486,025

Inventory (Narrative) (Details)

Inventory (Narrative) (Details) $ in Thousands	Dec. 31, 2020USD ($)
Fish In Process [Member]
Inventory [Line Items]
Inventory reserve	$ 1,530

Inventory (Schedule of Inventor

Inventory (Schedule of Inventory) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Inventory [Line Items]
Inventory, net	$ 1,259,910	$ 1,525,377
Feed [Member]
Inventory [Line Items]
Total Inventory	162,047	244,311
Eggs And Fry [Member]
Inventory [Line Items]
Total Inventory		54,929
Packaging [Member]
Inventory [Line Items]
Total Inventory		6,452
Fish In Process [Member]
Inventory [Line Items]
Total Inventory	$ 1,097,863	1,219,685
Less inventory reserve		$ (1,530,000)

Property, Plant and Equipment_2

Property, Plant and Equipment (Narrative) (Details) - USD ($)	1 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense		$ 1,800,000	$ 1,500,000
Proceeds from legal settlement, net	$ 1,000,000		1,014,008
Gross property, plant, and equipment		40,684,386	32,036,495
Construction In Process [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant, and equipment		8,119,575	$ 3,212,287
Ohio Farm [Member] | Capital Addition Purchase Commitments [Member]
Property, Plant and Equipment [Line Items]
Commitments to purchase property, plant, and equipment		12,200,000
Ohio Farm [Member] | Construction In Process [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant, and equipment		5,200,000
Rollo Bay Farm And Fortune Bay Hatchery [Member] | Construction In Process [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant, and equipment		2,000,000
Indiana Aquaculture Farm [Member] | Construction In Process [Member]
Property, Plant and Equipment [Line Items]
Gross property, plant, and equipment		$ 856,000

Property, Plant and Equipment_3

Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 40,684,386	$ 32,036,495
Less accumulated depreciation and amortization	(6,869,267)	(5,106,157)
Property, plant and equipment, net	33,815,119	26,930,338
Land [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	725,799	724,785
Building And Improvements [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	15,580,385	14,048,917
Construction In Process [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	8,119,575	3,212,287
Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	15,981,408	13,819,210
Office Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	240,939	202,596
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 36,280	$ 28,700

Debt (Narrative) (Details)

Debt (Narrative) (Details)

Jul. 31, 2025

Aug. 20, 2021USD ($)

Aug. 20, 2021CAD ($)

Jul. 31, 2020USD ($)

Sep. 30, 2020USD ($)

Sep. 30, 2020CAD ($)

Nov. 30, 2018

Feb. 29, 2016

Jan. 31, 2009

Dec. 31, 2021USD ($)

Dec. 31, 2020USD ($)

Dec. 31, 2018USD ($)

Oct. 12, 2021USD ($)

Oct. 11, 2021USD ($)

Apr. 27, 2021USD ($)

Apr. 27, 2021CAD ($)

Feb. 25, 2021USD ($)

Feb. 25, 2021CAD ($)

Dec. 31, 2018CAD ($)

Debt Instrument [Line Items]

Proceeds from issuance of debt

$ 606,453

$ 4,221,130

Loan settlement costs

91,620

Loans Payable [Member] | ACOA AIF Grant [Member]

Debt Instrument [Line Items]

Royalty percentage

10.00%

Maturity date

-

Interest rate

0.00%

Secured Debt [Member] | ACOA Term Loan #1 [Member]

Debt Instrument [Line Items]

Loan term

108 months

Maturity date

Feb 2027

Interest rate

0.00%

0.00%

Secured Debt [Member] | ACOA Term Loan #2 [Member]

Debt Instrument [Line Items]

Loan term

108 months

Maturity date

Sep 2029

Interest rate

0.00%

0.00%

Secured Debt [Member] | ACOA Term Loan #3 [Member]

Debt Instrument [Line Items]

Maturity date

Dec 2025

Interest rate

0.00%

Secured Debt [Member] | PEI Finance Term Loan [Member]

Debt Instrument [Line Items]

Amount borrowed

$ 1,500,000

$ 2,000,000

Maturity date

Nov 2023

Interest rate

4.00%

4.00%

4.00%

Loan repayment period

87 months

Secured Debt [Member] | First Farmers Bank & Trust [Member]

Debt Instrument [Line Items]

Amount borrowed

$ 4,000,000

Proceeds from issuance of debt

$ 3,900,000

Maturity date

Oct 2028

Interest rate

5.375%

5.375%

Loan settlement costs

$ 90,000

Interest rate, period

5 years

Interest only payment period

13 months

Covenant, minimum cash balance

$ 1,000,000

$ 500,000

Secured Debt [Member] | First Farmers Bank & Trust [Member] | Forecast

Debt Instrument [Line Items]

Maturity date

Oct. 1, 2028

Secured Debt [Member] | DFO Term Loan [Member]

Debt Instrument [Line Items]

Maturity date

Aug 2032

Interest rate

0.00%

Interest expense

$ 316,000

$ 152,000

Canadian Subsidiary [Member] | Secured Debt [Member] | ACOA Term Loan #3 [Member]

Debt Instrument [Line Items]

Loan term

36 months

36 months

Proceeds from issuance of debt

$ 200,075

$ 250,000

Interest rate

0.00%

0.00%

Canadian Subsidiary [Member] | Secured Debt [Member] | DFO Term Loan [Member]

Debt Instrument [Line Items]

Amount borrowed

$ 219,258

$ 276,840

$ 187,120

$ 238,400

Proceeds from issuance of debt

$ 1,400,000

$ 1,900,000

Maturity date

August 2032

US Treasury 5-Year Maturities Rate [Member] | First Farmers Bank & Trust [Member] | Forecast

Debt Instrument [Line Items]

Basis spread on variable rate

5.00%

Debt (Terms and Conditions of L

Debt (Terms and Conditions of Long-term Debt Outstanding) (Details)	Jul. 31, 2020USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2021CAD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2018	Nov. 30, 2018	Feb. 29, 2016
Debt Instrument [Line Items]
Total debt		$ 9,219,378		$ 8,874,495
less: debt issuance costs		(68,680)		(86,066)
less: current portion		(627,365)		(259,939)
Long-term debt, net		$ 8,523,333		8,528,490
Loans Payable [Member] | ACOA AIF Grant [Member]
Debt Instrument [Line Items]
Interest rate		0.00%
Maturity date		-	-
Total debt		$ 2,261,349		2,253,595
Secured Debt [Member] | ACOA Term Loan #1 [Member]
Debt Instrument [Line Items]
Interest rate		0.00%					0.00%
Monthly repayment			$ 3,120
Maturity date		Feb 2027	Feb 2027
Total debt		$ 152,346		181,203
Secured Debt [Member] | ACOA Term Loan #2 [Member]
Debt Instrument [Line Items]
Interest rate		0.00%				0.00%
Monthly repayment			$ 4,630
Maturity date		Sep 2029	Sep 2029
Total debt		$ 339,015		381,451
Secured Debt [Member] | ACOA Term Loan #3 [Member]
Debt Instrument [Line Items]
Interest rate		0.00%
Monthly repayment			$ 6,945
Maturity date		Dec 2025	Dec 2025
Total debt		$ 196,850
Secured Debt [Member] | Kubota Canada Ltd [Member]
Debt Instrument [Line Items]
Interest rate		0.00%
Monthly repayment			$ 1,142
Maturity date		Jan 2025	Jan 2025
Total debt		$ 33,283		43,925
Secured Debt [Member] | PEI Finance Term Loan [Member]
Debt Instrument [Line Items]
Interest rate		4.00%			4.00%
Monthly repayment			$ 16,313
Maturity date		Nov 2023	Nov 2023
Total debt		$ 1,947,510		2,014,321
Secured Debt [Member] | DFO Term Loan [Member]
Debt Instrument [Line Items]
Interest rate		0.00%
Monthly repayment			$ 2,091
Maturity date		Aug 2032	Aug 2032
Total debt		$ 405,700
Secured Debt [Member] | First Farmers Bank & Trust [Member]
Debt Instrument [Line Items]
Interest rate	5.375%	5.375%
Monthly repayment	$ 57,000	$ 56,832
Maturity date		Oct 2028	Oct 2028
Total debt		$ 3,883,325		$ 4,000,000

Debt (Principal Payments Due on

Debt (Principal Payments Due on Long-term Debt) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Year
2022	$ 643,980
2023	2,564,347
2024	729,626
2025	750,175
2026	715,392
Thereafter	3,815,858
Total debt	$ 9,219,378	$ 8,874,495

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($)	Feb. 08, 2021	Dec. 14, 2020	Dec. 31, 2021	Dec. 31, 2020
Stockholders' Equity
Authorized shares of common and preferred stock			85,000,000
Authorized shares of preferred stock			5,000,000
Issued shares of preferred stock			0	0
Outstanding shares of preferred stock			0	0
Issued shares of common stock			71,025,738	55,497,133
Outstanding shares of common stock			71,025,738	55,497,133
Common stock, voting rights, number of votes per share			one
Value of equity subscription			$ 119,120,437	$ 104,625,615
Share-based Compensation
Share-based compensation expense			394,237	436,691
Share-based compensation			394,237	436,691
Restricted Stock [Member]
Share-based Compensation
Share-based compensation expense			240,000	227,000
Unearned share-based compensation expense in future periods			$ 147,000
Unearned share-based compensation earn period			2 years 2 months 12 days
Stock Option [Member]
Share-based Compensation
Share-based compensation expense			$ 154,000	$ 251,000
Unearned share-based compensation expense in future periods			$ 182,000
Unearned share-based compensation earn period			2 years 2 months 12 days
Exercisable term			10 years
Weighted average fair value of stock options grants (in dollars per share)			$ 5.36	$ 1.49
Exercised (in shares)			16,667	0
Intrinsic value of options exercised			$ 41,000	$ 0
Intrinsic value of options outstanding			18,000,000	3,600,000
Intrinsic value of exercisable options			$ 11,000,000	$ 3,200,000
Expected volatility			111.00%
Risk free interest rate			0.80%
Expected dividend yield			0.00%	0.00%
Expected life (in years)			5 years	5 years
Minimum [Member] | Stock Option [Member]
Share-based Compensation
Award vesting period			1 year
Expected volatility				101.00%
Risk free interest rate				0.31%
Maximum [Member] | Stock Option [Member]
Share-based Compensation
Award vesting period			3 years
Expected volatility				104.00%
Risk free interest rate				1.67%
2016 Equity Incentive Plan [Member] | Restricted Stock [Member]
Share-based Compensation
Shares authorized to grant			1,900,000
Shares reserved for future issuance			916,516
Warrant [Member]
Warrants [Abstract]
Expiration date			Jan. 17, 2023
Share-based Compensation
Exercised (in shares)			530,414
Common Stock [Member]
Stockholders' Equity
Issued (in shares)			14,950,000	33,028,000
Value of equity subscription			$ 14,950	$ 33,028
Share-based Compensation
Exercised (in shares)			4,354
December 2020 Public Offering [Member] | Common Stock [Member]
Stockholders' Equity
Issued (in shares)		33,028,000
Proceeds from issuance or sale of equity		$ 104,600,000
February 2021 Public Offering [Member] | Common Stock [Member]
Stockholders' Equity
Issued (in shares)	14,950,000
Proceeds from issuance or sale of equity	$ 119,100,000

Stockholders' Equity (Informati

Stockholders' Equity (Information About Outstanding Warrants) (Details) - Warrant [Member]	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Number of options
Outstanding, beginning balance | shares	948,855
Issued | shares
Exercised | shares	(530,414)
Expired | shares
Outstanding, ending balance | shares	418,441
Exercisable | shares	418,441
Weighted average exercise price
Outstanding, beginning balance | $ / shares	$ 3.25
Granted | $ / shares
Exercised | $ / shares	3.25
Expired | $ / shares
Outstanding, ending balance | $ / shares	3.25
Exercisable | $ / shares	$ 3.25

Stockholders' Equity (Restricte

Stockholders' Equity (Restricted Stock Activity) (Details) - Restricted Stock [Member]	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Shares
Beginning balance | shares	92,653
Granted | shares	43,837
Vested | shares	(71,390)
Ending balance | shares	65,100
Weighted average grant date fair value
Beginning balance | $ / shares	$ 1.93
Granted | $ / shares	6.67
Vested | $ / shares	2.86
Ending balance | $ / shares	$ 4.10

Stockholders' Equity (Stock Opt

Stockholders' Equity (Stock Option Activity) (Details) - Stock Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Number of options
Outstanding, beginning balance	657,414
Granted	48,914
Exercised	(16,667)	0
Forfeited	(1,959)
Expired	(24,277)
Outstanding, ending balance	663,425	657,414
Exercisable	607,189
Weighted average exercise price
Outstanding, beginning balance	$ 4.28
Granted	6.72
Exercised	6.90
Forfeited	6.72
Expired	6.36
Outstanding, ending balance	4.31	$ 4.28
Exercisable	$ 4.33

Stockholders' Equity (Informa_2

Stockholders' Equity (Information About Options Outstanding and Exercisable) (Details) - Stock Option [Member]	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding	663,425
Number of options exercisable	607,189
$1.88 - $2.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding	524,019
Weighted average remaining estimated life (in years)	7 years 3 months 18 days
Number of options exercisable	493,772
$3.30 - $6.72
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding	53,916
Weighted average remaining estimated life (in years)	8 years 4 months 24 days
Number of options exercisable	27,927
$7.50 - $10.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding	16,403
Weighted average remaining estimated life (in years)	2 years 3 months 18 days
Number of options exercisable	16,403
$14.20 - $23.40
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding	69,087
Weighted average remaining estimated life (in years)	4 years 2 months 12 days
Number of options exercisable	69,087
Minimum [Member] | $1.88 - $2.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	$ 1.88
Minimum [Member] | $3.30 - $6.72
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	3.30
Minimum [Member] | $7.50 - $10.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	7.50
Minimum [Member] | $14.20 - $23.40
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	14.20
Maximum [Member] | $1.88 - $2.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	2.50
Maximum [Member] | $3.30 - $6.72
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	6.72
Maximum [Member] | $7.50 - $10.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	10.80
Maximum [Member] | $14.20 - $23.40
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average exercise price of outstanding options | $ / shares	$ 23.40

Stockholders' Equity (Stock O_2

Stockholders' Equity (Stock Option Grants Weighted Average Assumptions) (Details) - Stock Option [Member]	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	111.00%
Risk free interest rate	0.80%
Expected dividend yield	0.00%	0.00%
Expected life (in years)	5 years	5 years
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility		101.00%
Risk free interest rate		0.31%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility		104.00%
Risk free interest rate		1.67%

Stockholders' Equity (Share-bas

Stockholders' Equity (Share-based Compensation Costs Recognized on Financial Statements) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation	$ 394,237	$ 436,691
Research And Development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation		497
General And Administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Total share-based compensation	$ 394,237	$ 436,194

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) $ in Millions	Dec. 31, 2021USD ($)
Domestic Tax Authority [Member]
Tax Credit Carryforward [Line Items]
Domestic operating loss carryforwards	$ 50
Domestic Tax Authority [Member] | Limitations On Use To Section 382 [Member]
Tax Credit Carryforward [Line Items]
Domestic operating loss carryforwards	78
Foreign Tax Authority [Member]
Tax Credit Carryforward [Line Items]
Foreign operating loss carryforwards	11
Foreign Tax Authority [Member] | Research Tax Credit Carryforward [Member]
Tax Credit Carryforward [Line Items]
Foreign research and development tax credit carryforwards	$ 2

Income Taxes (Components of Los

Income Taxes (Components of Loss Before Income Taxes) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Domestic	$ (21,105,065)	$ (15,768,224)
Foreign	(1,217,523)	(631,761)
Loss before income taxes	$ (22,322,588)	$ (16,399,985)

Income Taxes (Schedule of Effec

Income Taxes (Schedule of Effective Income Tax Rate Reconciliation) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Income tax benefit	$ (4,687,744)	$ (3,443,997)
State and provincial income tax, net of federal benefit	(1,157,840)	(732,994)
Permanent differences	202,583	131,141
US-Foreign rate differential	39,045	(142,663)
Other, net	(299,071)	(145,973)
Total income tax, prior to change in valuation allowance	(5,903,027)	(4,334,486)
Change in valuation allowance	5,903,027	4,334,486
Total income tax

Income Taxes (Components of Def

Income Taxes (Components of Deferred Tax Assets and Liabilities) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Income Taxes [Abstract]
Net operating loss carryforwards	$ 23,216,863	$ 16,964,199
Foreign research and development tax credit carryforwards	2,428,663	2,679,180
Property and equipment	145,530	56,697
Intangibles and other	2,934,441	3,122,394
Total deferred tax assets	28,725,497	22,822,470
Valuation allowance	(28,725,497)	(22,822,470)
Net deferred tax assets

Commitments and Contingencies_2

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Commitments and Contingencies [Abstract]
Lease expense	$ 84	$ 86
Lease payment	$ 84	$ 85
Weighted average remaining lease term	24 years 1 month 6 days

Commitments and Contingencies_3

Commitments and Contingencies (Summary of Lease Obligations) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2019
Commitments and Contingencies [Abstract]
Total leases	$ 290,327	$ 352,810	$ 532,000
Less: current portion	(66,269)	(62,483)
Long-term leases	$ 224,058	$ 290,327

Commitments and Contingencies_4

Commitments and Contingencies (Summary of Remaining Payments under Leases) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Jan. 01, 2019
Commitments and Contingencies [Abstract]
2022	$ 84,080
2023	33,872
2024	17,481
2025	18,006
2026	18,546
Thereafter	583,328
Total Lease Payments	755,313
Less: imputed interest	(464,986)
Total leases	$ 290,327	$ 352,810	$ 532,000

Retirement Plan (Details)

Retirement Plan (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Defined Contribution Plan Disclosure [Line Items]
Employer contributions to retirement plan	$ 81	$ 72
Canada
Defined Contribution Plan Disclosure [Line Items]
Employer contributions to retirement plan	$ 38	$ 32

Related Party Agreement (Detail

Related Party Agreement (Details) - TS Aquaculture [Member] - USD ($) $ in Thousands	Nov. 23, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Shares sold in public offering	12,880,000
Expenses incurred		$ 418